Abstract:A modularized DNA nanodevice agonist (DNDA) has been rationally designed and constructed as both a nanocarrier and agonist. DNA‐based modules with desired functions enable DNDA to accomplish macrophage‐selective uptake and programmable cGAS‐STING activation. By reversing the immunosuppressive tumor microenvironment, DNDA exhibits a synergistic therapeutic effect when combined with immune checkpoint inhibitors. The cell‐selective STING activation with biocompatibility makes it potential for clinical translation. The activation of cyclic GMP‐AMP (cGAMP) synthase (cGAS) and its adaptor, stimulator of interferon genes (STING), is known to reprogram the immunosuppressive tumor microenvironment for promoting antitumor immunity. To enhance the efficiency of cGAS‐STING pathway activation, macrophage‐selective uptake, and programmable cytosolic release are crucial for the delivery of STING agonists. However, existing polymer‐ or lipid‐based delivery systems encounter difficulty in integrating multiple functions meanwhile maintaining precise control and simple procedures. Herein, inspired by cGAS being a natural DNA sensor, a modularized DNA nanodevice agonist (DNDA) is designed that enable macrophage‐selective uptake and programmable activation of the cGAS‐STING pathway through precise self‐assembly. The resulting DNA nanodevice acts as both a nanocarrier and agonist. Upon local administration, it demonstrates the ability of macrophage‐selective uptake, endosomal escape, and cytosolic release of the cGAS‐recognizing DNA segment, leading to robust activation of the cGAS‐STING pathway and enhanced antitumor efficacy. Moreover, DNDA elicits a synergistic therapeutic effect when combined with immune checkpoint blockade. The study broadens the application of DNA nanotechnology as an immune stimulator for cGAS‐STING activation.

Investigation and Regulation of DNA Nanostructures on Activating cGAS-STING Signaling

Cellular functions of cGAS-STING signaling

Chemical regulation of the cGAS-STING pathway

DNA PAMPs as Molecular Tools for the cGAS-STING Signaling Pathways

The molecular mechanism of dsDNA sensing through the cGAS-STING pathway

Photoactivated DNA Assembly and Disassembly for On-Demand Activation and Termination of cGAS-STING Signaling.

Cgas-Sting: the Novel Mechanism of Cytosolic DNA Sensing Pathways

Recent Advances in the Activation and Regulation of the Cgas-Sting Pathway.

The Mechanism of Double-Stranded DNA Sensing Through the Cgas-Sting Pathway.

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

Advances in structure-guided mechanisms impacting on the cGAS-STING innate immune pathway

MicroRNA‐Responsive DNA Dendrimer Acts As a Smart STING Signal Amplifier

DNA mechanical flexibility controls DNA potential to activate cGAS-mediated immune surveillance

A DNA‐Modularized STING Agonist with Macrophage‐Selectivity and Programmability for Enhanced Anti‐Tumor Immunotherapy

Innate Immune Stimulation using 3D Wireframe DNA Origami

Dynamic regulation of DNA nanostructures by noncanonical nucleic acids

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

DNA Sensor Cgas-Mediated Immune Recognition

Cytosolic Sensing of Aberrant DNA: Arming STING on the Endoplasmic Reticulum

Recent Progress on the Activation of the Cgas–sting Pathway and Its Regulation by Biomolecular Condensation

New Frontiers on Intracellular cGAS Activation: Molecular Mechanisms, Cellular Signaling, and Therapeutic Strategies